Filing Details

Accession Number:
0001477932-23-009055
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-11 08:51:32
Reporting Period:
2023-12-08
Accepted Time:
2023-12-11 08:51:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1340610 John Cameron Reynolds 1489 West Warm Springs Road
Suite 110
Henderson NV 89014
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-08 10,000 $0.67 1,704,518 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,007,718 Indirect By Concord International, Inc.
Common Stock 34,076 Indirect By Spouse
Footnotes
  1. The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.